Morpheus Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 9.78 Cr
as on 13-12-2024
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.41 Cr
as on 13-12-2024
- Satisfied Charges ₹ 1.18 M
as on 13-12-2024
- Revenue 2.55%
(FY 2022)
- Profit 37.21%
(FY 2022)
- Ebitda 72.00%
(FY 2022)
- Net Worth -16.21%
(FY 2022)
- Total Assets -26.04%
(FY 2022)
About Morpheus Life Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.78 Cr.
The company currently has active open charges totaling ₹3.41 Cr. The company has closed loans amounting to ₹1.18 M, as per Ministry of Corporate Affairs (MCA) records.
Milind Vaidya, Raj Parekh, Arvind Chandra, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74900MH2009PTC193572
- Company No.
193572
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jun 2009
- Date of AGM
10 Nov 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Morpheus Life Sciences?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Frank Riemer  | Director | 26-Mar-2010 | Current |
| Arvind Chandra | Director | 26-Mar-2010 | Current |
Milind Vaidya  | Director | 23-Sep-2013 | Current |
| Raj Parekh | Director | 24-Jul-2009 | Current |
| Michael Dumschat | Director | 26-Mar-2010 | Current |
Financial Performance and Corporate Structure Insights of Morpheus Life Sciences.
Morpheus Life Sciences Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.55% increase. The company also saw a substantial improvement in profitability, with a 37.21% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Morpheus Life Sciences?
In 2022, Morpheus Life Sciences had a promoter holding of 85.01% and a public holding of 14.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 07 Aug 2020 | ₹5.00 M | Open |
Hdfc Bank Limited Creation Date: 14 Jul 2020 | ₹2.56 M | Open |
Hdfc Bank Limited Creation Date: 09 Aug 2018 | ₹4.50 M | Open |
How Many Employees Work at Morpheus Life Sciences?
Morpheus Life Sciences has a workforce of 15 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Morpheus Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Morpheus Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
